Jianyang Fang

4221-116 Xiang'an South Road
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Theranostic Study of PSMA-Targeted Radioligands Modified with Enhancer SNAC.

Theranostic Study of PSMA-Targeted Radioligands Modified with Enhancer SNAC.

Journal: Journal of medicinal chemistry

Published: May 13, 2026

Development of Lipid-Engineered PSMA-Targeted Radioligands with Quinoline Scaffold.

Development of Lipid-Engineered PSMA-Targeted Radioligands with Quinoline Scaffold.

Journal: Journal of medicinal chemistry

Published: April 22, 2026

Development of a Novel Approach for In Vivo Tumor Hypoxia PET Imaging with Nitroreductase-Specific Responsive Radiotracers.

Development of a Novel Approach for In Vivo Tumor Hypoxia PET Imaging with Nitroreductase-Specific Responsive Radiotracers.

Journal: Molecular pharmaceutics

Published: February 18, 2026

Exploration of Bicyclic Peptide Ligands for Immune-Specific PET Imaging: Targeting Tumor PD-L1 with [18F]AlF-BCY10959.

Exploration of Bicyclic Peptide Ligands for Immune-Specific PET Imaging: Targeting Tumor PD-L1 with [18F]AlF-BCY10959.

Journal: Molecular pharmaceutics

Published: May 09, 2025

Modification of Asp-Peptide Adapters: Giving the FAP-Targeted Radioligand a "Squirrel Tail".

Modification of Asp-Peptide Adapters: Giving the FAP-Targeted Radioligand a "Squirrel Tail".

Journal: Journal of medicinal chemistry

Published: March 18, 2025

68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study.

68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 14, 2025

Development of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid for theranostic applications.

Development of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid for theranostic applications.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 28, 2024

FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics.

FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 04, 2024

Development of Preladenant-Based Radiotracers for Imaging A2AR in Tumors.

Development of Preladenant-Based Radiotracers for Imaging A2AR in Tumors.

Journal: Journal of medicinal chemistry

Published: July 22, 2024

Development of STING probes and visualization of STING in multiple tumor types.

Development of STING probes and visualization of STING in multiple tumor types.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 13, 2024

Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers.

Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers.

Journal: Journal of medicinal chemistry

Published: May 10, 2024

Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types.

Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types.

Journal: Journal of medicinal chemistry

Published: May 08, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026